By Judith Wasserheit and Larry CoreySpecial to The Times
The holidays are upon us, albeit the magic of extended time with family and friends, mixed with stories of miracles and wonderful gifts, appears more imagery this year than reality.
By Sandi Doughton Seattle Times staff reporter
We’ve all noticed that fellow shopper at the grocery store with a mask snugged over his mouth — but not his nose. Maybe you’ve also got a neighbor who tugs her mask down to talk. Or perhaps you’ve detoured around groups of barefaced teenagers jostling each other in a park.
Céline Gounder, MD, has been appointed to President-elect Joe Biden’s COVID-19 task force. She is a UW School of Medicine graduate and is among the first cohort of UW Global Health medical students; she helped initiate the UW SOM International Health Group, establishing what are now the Dept.
By Laurie McGinley, Lena H. Sun and Carolyn Y. JohnsonNovember 9, 2020 at 5:20 p.m. PST
By Gina Kolata, NYTimes
A committee that advises the C.D.C.’s director is working on a plan to equitably distribute immunizations when they become available.
Most countries world-wide implemented localized or national school closures in response to the COVID-19 pandemic, with estimates of >65% of enrolled children globally affected by school closures.1 Since the early pandemic, schools in many settings around the world have fully or partially re-opened for in-person instruction, while in other settings schools have re-opened exclusively using online learning.
More than 5,200 viewers joined us last week for the Johns Hopkins University–University of Washington symposium “Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation.” |
For the founder of the Vaccine Confidence Project, squashing viral rumors means building trust — and avoiding the term “anti-vaxxer.”
By Jenny Anderson, NYTimes
UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.
Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients.
By Ryan Blethen Seattle Times staff reporter
Nearly eight months after the pandemic was declared, researchers are gaining a more complete understanding of how the new coronavirus affects people.
One thing they’re noticing as time goes on: some people diagnosed with COVID-19 feel sick long after contracting the virus.